Two factors speak to the need for this module. The first is that it speaks to a newly emergent population--young adults whose first experience with nicotine was an electronic device between the years 2018-2020 when such use was labeled "epidemic." They are now adults potentially arriving to Colorado pharmacies seeking assistance to stop using ENDS. Second, there is widespread misinformation about the role of nicotine in causing disease and, relatedly, whether ENDS offer a harm reduction pathway to current adult smokers. Many healthcare providers are under the wrongful notion that nicotine contributes to the major harms of cigarette use. This could unduly interfere with the ability to respond accurately to smokers about ENDS as an alternative to cigarettes.
At the end of this module pharmacist will be able to: